Oruka Therapeutics’ (ORKA) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a report released on Friday,Benzinga reports. The firm currently has a $45.00 price objective on the stock. Other equities research analysts have also recently issued research reports about the stock. Wedbush restated an “outperform” rating and issued a $40.00 […]
HC Wainwright restated their buy rating on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a report released on Friday,Benzinga reports. The firm currently has a $45.00 price objective on the stock. Other equities research analysts have also recently issued research reports about the stock. Wedbush restated an “outperform” rating and issued a $40.00 […]
